Free Trial

Zymeworks (ZYME) Insider Trading & Ownership

Zymeworks logo
$23.80 -0.23 (-0.97%)
As of 11:17 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Zymeworks (NASDAQ:ZYME) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
33.51%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$635.53K
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$4.67M
Get ZYME Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zymeworks stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZYME Insider Buying and Selling by Quarter

Zymeworks Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/12/2026Sell9,310$22.67$211,057.70  
1/12/2026Sell30,424$22.67$689,712.08  
1/12/2026Sell6,120$22.67$138,740.40  
1/12/2026Sell9,560$22.67$216,725.20  
1/5/2026Sell10,538$25.10$264,503.80  
1/5/2026Sell54,343$25.10$1,364,009.30  
1/5/2026Sell20,110$25.10$504,761.00  
12/22/2025Sell47,528$27.02$1,284,206.56  
5/19/2025
Ecor1 Capital, Llc
Director
Buy5,919$11.78$69,725.82  
5/15/2025
Ecor1 Capital, Llc
Director
Buy49,502$11.43$565,807.86  
(Data available from 1/1/2013 forward)

ZYME Insider Trading Activity - Frequently Asked Questions

The list of insiders at Zymeworks includes Christopher Astle, Ecor1 Capital, Llc, Jeffrey T L Smith, Kenneth Galbraith, Mark Hollywood, and Paul Andrew Moore. Learn more on insiders at ZYME.

33.51% of Zymeworks stock is owned by insiders. Learn more on ZYME's insider holdings.

The following insider purchased ZYME shares in the last 24 months: Ecor1 Capital, Llc ($25,157,739.97).

Insiders have purchased a total of 2,009,307 ZYME shares in the last 24 months for a total of $25,157,739.97 bought.

The following insiders have sold ZYME shares in the last 24 months: Jeffrey T L Smith ($641,322.70), Kenneth Galbraith ($4,192,709.66), Mark Hollywood ($138,740.40), and Paul Andrew Moore ($1,037,790.20).

Insiders have sold a total of 277,534 Zymeworks shares in the last 24 months for a total of $6,010,562.96 sold.



This page (NASDAQ:ZYME) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners